References
- http://emedicine.medscape.com/article/2087469-overview (assessed Nov 26, 2013)
- Habener JF. Regulation of parathyroid hormone secretion and biosynthesis. Annu Rev Physiol. 1981;43:211-223. https://doi.org/10.1146/annurev.ph.43.030181.001235
- Nemeth EF. Pharmacological regulation of parathyroid hormone secretion. Curr Pharm Des. 2002;8:2077-2087. https://doi.org/10.2174/1381612023393387
- Jacqmin P, Snoeck E, van Schaick EA, Gieschke R, Pillai P, Steimer JL, Girard P. Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model. J Pharmacokinet Pharmacodyn. 2007;34:57-85. https://doi.org/10.1007/s10928-006-9035-z
- Keizer RJ, van Benten M, Beijnen JH, Schellens JH, Huitema AD. Pirana and PCluster: a modeling environment and cluster infrastructure for NONMEM. Comput Methods Programs Biomed. 2011;101:72-79. https://doi.org/10.1016/j.cmpb.2010.04.018
- Abraham AK, Mager DE, Gao X, Li M, Healy DR, MaurerTS. Mechanism-based pharmacokinetic/pharmacodynamic model of parathyroid hormone-calcium homeostasis in rats and humans. J Pharmacol Exp Ther. 2009;330:169-178. https://doi.org/10.1124/jpet.109.152033
- Bieglmayer C, Prager G, Niederle B. Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem. 2002;48: 1731-1738.
- Shrestha RP, Hollot CV, Chipkin SR, Schmitt CP, Chait Y. A mathematical model of parathyroid hormone response to acute changes in plasma ionized calcium concentration in humans. Math Biosci. 2010;226:46-57. https://doi.org/10.1016/j.mbs.2010.04.001
- Heaney RP. Quantifying human calcium absorption using pharmacokinetic methods. J Nutr. 2003;133:1224-1226. https://doi.org/10.1093/jn/133.4.1224
Cited by
- Mood disorder as a manifestation of primary hypoparathyroidism: a case report vol.8, pp.1, 2014, https://doi.org/10.1186/1752-1947-8-326
- Dose-Response-Time Data Analysis: An Underexploited Trinity vol.71, pp.1, 2014, https://doi.org/10.1124/pr.118.015750